398 related articles for article (PubMed ID: 19022520)
1. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
[TBL] [Abstract][Full Text] [Related]
2. Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments.
Malentacchi F; Vinci S; Della Melina A; Kuncova J; Villari D; Giannarini G; Nesi G; Selli C; Orlando C
Urol Oncol; 2012; 30(3):278-84. PubMed ID: 20875751
[TBL] [Abstract][Full Text] [Related]
3. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P
Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C
Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206
[TBL] [Abstract][Full Text] [Related]
5. High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer.
Ilie M; Mazure NM; Hofman V; Ammadi RE; Ortholan C; Bonnetaud C; Havet K; Venissac N; Mograbi B; Mouroux J; Pouysségur J; Hofman P
Br J Cancer; 2010 May; 102(11):1627-35. PubMed ID: 20461082
[TBL] [Abstract][Full Text] [Related]
6. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
[TBL] [Abstract][Full Text] [Related]
7. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype.
Barathova M; Takacova M; Holotnakova T; Gibadulinova A; Ohradanova A; Zatovicova M; Hulikova A; Kopacek J; Parkkila S; Supuran CT; Pastorekova S; Pastorek J
Br J Cancer; 2008 Jan; 98(1):129-36. PubMed ID: 18026188
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
10. [Expression of carbonic anhydrase IX in NSCLC and its relationship with VEGF and Ki67 expression].
Zhao X; Liu X; Guo W; Li X
Zhongguo Fei Ai Za Zhi; 2010 Sep; 13(9):861-6. PubMed ID: 20840814
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C
Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
14. Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers.
Malentacchi F; Vinci S; Melina AD; Kuncova J; Villari D; Nesi G; Selli C; Orlando C; Pazzagli M; Pinzani P
Urol Oncol; 2016 Jul; 34(7):292.e9-292.e16. PubMed ID: 27005925
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ
Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker.
Klatte T; Seligson DB; Rao JY; Yu H; de Martino M; Kawaoka K; Wong SG; Belldegrun AS; Pantuck AJ
Cancer; 2009 Apr; 115(7):1448-58. PubMed ID: 19195047
[TBL] [Abstract][Full Text] [Related]
20. High stromal carbonic anhydrase IX expression is associated with nodal metastasis and decreased survival in patients with surgically-treated oral cavity squamous cell carcinoma.
Brockton NT; Klimowicz AC; Bose P; Petrillo SK; Konno M; Rudmik L; Dean M; Nakoneshny SC; Matthews TW; Chandarana S; Lau HY; Magliocco AM; Dort JC
Oral Oncol; 2012 Jul; 48(7):615-22. PubMed ID: 22366443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
